WATCH NOW
NBC 17 takes you to the NC State Veterinary School and shows you a study which is looking for a new treatment for seizures in dogs.
North Carolina State University’s College of Veterinary Medicine (CVM) is participating in a national clinical trial evaluating a new drug to treat canine idiopathic epilepsy—a chronic condition affecting some four million dogs that is characterized by recurring seizures for which an underlying cause has not been identified.
The largest clinical trial of its kind, the blinded study is sponsored by a major animal health pharmaceutical company and is regulated by the Food and Drug Administration. Hundreds of dogs at multiple investigator sites across the country are participating in the study, which will help build a body of evidence-based research that may lead to new insights into canine idiopathic epilepsy and its treatment.
“We are excited to take part in this study which may offer additional treatment options to pets with epilepsy,” says Dr. Karen Munana, associate professor of neurology.“We are constantly trying to research the causes, diagnostic options, and treatments for epilepsy in dogs. Epilepsy is one disease that can impact the human-animal bond to a huge extent.”
February is National Pet Dental Health Month
Register Now for Horseman's Youth Day March 6
Researchers Study Gene Critical in Cancer, Animal Development
One of the Family: Animal Care Drives CVM Innovations
CCMTR Researchers Advance Understanding of Nervous System
Dr. Ferris Investigates Animal Cruelty for State of North Carolina
CVM Researchers Study Migration of Nanoparticles
VTH Saves K-9 Officer Kito (video)